Histopathology of Basal Cell Carcinoma After Treatment with Vismogedib

Tang, J.C..; Buckel, L.; Hanke, C.. W.

Journal of Drugs in Dermatology Jdd 18(2): 136-138

2019


ISSN/ISBN: 1545-9616
PMID: 30794363
Document Number: 17715
Background: Vismodegib used in the treatment of metastatic basal cell carcinoma (BCC) or locally advanced, recurrent BCC not amenable to surgery or radiation leads to various clinical changes.

Document emailed within 1 workday
Secure & encrypted payments

Histopathology of Basal Cell Carcinoma After Treatment with Vismogedib